Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Morrisons Announces Plans to Close 100 Stores Amid Rising Cost Pressures Microsofts GitHub Faces AI Coding Race Challenges Amid Outages and Competition Perpetua Resources Secures 29 Billion Loan from US ExportImport Bank Ella Langley Dominates Billboard Hot 100 Outpacing Ariana Grande and Mariah Careys SingleFrame Feats Trainline Raises FullYear Guidance for Second Time This Year MSAI Q1 2026 Earnings EPS Surprise Beats Estimates Stock Rises Amid Revenue Uncertainty VRTS Q1 2026 Earnings EPS Misses Estimates on Negative Surprise SoFi Q1 2026 Earnings EPS Falls Just Shy of Estimates Stock Declines MasTec MTZ Q1 2026 Earnings EPS Surges 39 Above Estimates Stock Slips Despite Strong Beat Coastal Financial Corporation Q1 2026 Earnings EPS Misses Estimates by 261 as Stock Declines Olin Corporation OLN Holds Steady Near Support as Volatility Remains Subdued Odyssey Marine Exploration OMEX Holds Near Support After Modest Daily Gain Whats Next Biodexa Pharmaceuticals BDRX Edges Higher as Stock Tests Key Resistance Levels Arqit Quantum Warrants ARQQW Hover at 008 as Slight Gains Follow Small Uptick Oil Markets on Edge as Potential Strait of Hormuz Fees Loom Investors Cautious Amazon Sets Record Sales in Thanksgiving Holiday Week Highlighting ECommerce Strength Evercore ISI Lifts Price Target on Cummins Signaling Confidence in Industrial Growth Tracker Mortgages Regain Popularity Amid Uncertain Interest Rate Outlook Is a Tracker Right for You Soleno Therapeutics SLNO Market Leadership Q4 2025 EPS Beats Forecasts Why Eaton ETV could deliver where others fall short Bearish Sentiment 20260507 Kingstone Companies KINS Stock Why LongTerm Investors Hold It Pushes Higher 20260415 Why Ohmyhome OMH looks attractive at current levels Loses Ground 20260508 AEHR Aehr Test Systems shares jump 1042 percent after Q1 2026 EPS beats consensus estimates by 30 percent MXCT MaxCyte Inc shares climb more than four percent after Q4 2025 EPS tops consensus analyst expectations